Current Month 2011
Article Features
  Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients
Advantages and Motivations Uncertain Behind Use of Brachytherapy for Breast Cancer Radiotherapy
Bilateral Oophorectomy Associated with Higher Prevalence of Low Bone Mineral Density and Arthritis in Younger Women
Breast Cancer Patients Face Increasing Number of Imaging Visits Before Surgery
Breast Cancer Survivors Struggle with Cognitive Problems Several Years After Treatment
Circulating Tumor Cells Not Linked to Survival in Newly Diagnosed Inflammatory Breast Cancer
Engineers Develop More Effective MRI Contrast Agent for Cancer Detection
Gene Inheritance Patterns Influence Age of Diagnosis in BRCA Families
Genome Sequencing Points to New Treatments for Triple-Negative Breast Cancer
Growth Factor Linked to Breast Cancer
Intermittent, Low-Carbohydrate Diets More Successful Than Standard Dieting
Loss of RB in Triple-Negative Breast Cancer Associated with Favorable Clinical Outcome
Many Women Do Not Undergo Breast Reconstruction After Mastectomy
MRI May Be Noninvasive Method to Measure Breast Cancer Prognosis
New Target Found for Aggressive Cancer Gene
No Brakes on Breast Cancer Cells
Potential Breast Cancer Prevention Agent Found to Lower Levels of “Good” Cholesterol Over Time
Risk for Developing Cancer in Other Breast Increased for Survivors with BRCA Mutation
Scientists Develop Vaccine That Attacks Breast Cancer in Mice
Starch Intake May Influence Risk for Breast Cancer Recurrence
Study Reveals How Normal Cells Fuel Tumor Growth
Why Women Quit Breast Cancer Drugs Early


Breast Cancer Survivors Struggle with Cognitive Problems Several Years After Treatment

A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation only. Published in the journal Cancer, the study indicates that there may be common and treatment-specific ways that cancer therapies negatively affect cancer survivors' mental abilities.

Previous research suggests that chemotherapy can cause problems with memory and concentration in breast cancer survivors. To compare the effects of different types of cancer treatment on such mental abilities, Paul Jacobsen, PhD, of the Moffitt Cancer Center and Research Institute in Tampa, and his colleagues examined 62 breast cancer patients treated with chemotherapy plus radiation, 67 patients treated with radiation only, and 184 women with no history of cancer. Study participants completed neuropsychological assessments six months after completing treatment and again 36 months later, which is further out from the end of treatment than most previous studies of this type.

The study confirmed that chemotherapy can cause cognitive problems in breast cancer survivors that persist for three years after they finish treatment. In addition, the investigators found that breast cancer survivors who had been treated with radiation (and not chemotherapy) often experienced problems similar to those in breast cancer survivors treated with both chemotherapy and radiation. They did not find that hormonal therapy (such as tamoxifen) caused cognitive difficulties.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon